# The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)

> **NCT05573100** · PHASE2 · COMPLETED · sponsor: **Curacle Co., Ltd.** · enrollment: 67 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** CU06-1004

## Key facts

- **NCT ID:** NCT05573100
- **Lead sponsor:** Curacle Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-12-21
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 67 (ACTUAL)
- **Last updated:** 2024-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05573100

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05573100, "The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05573100. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*